BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22347323)

  • 1. The therapeutic effect of cytokine-induced killer cells on pancreatic cancer enhanced by dendritic cells pulsed with K-ras mutant peptide.
    Tan G; Zhang X; Feng H; Luo H; Wang Z
    Clin Dev Immunol; 2011; 2011():649359. PubMed ID: 22347323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CTLs by DCs pulsed with K-ras mutant peptide on the surface of nanoparticles in the treatment of pancreatic cancer.
    Tan G; Wang Z; Zhang X; Cai Z; Zhang J
    Oncol Rep; 2011 Jul; 26(1):215-21. PubMed ID: 21573499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Killing activity of co-cultured cytokine-induced killer cells and dendritic cells against multi-drug resistant tumor cell lines].
    Li SJ; Zhang LS; Chai Y; Zhang YF; Zhang YM; Zeng PY; Wu CY
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):733-7. PubMed ID: 18396683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic carcinoma-specific immunotherapy using synthesised alpha-galactosyl epitope-activated immune responders: findings from a pilot study.
    Qiu Y; Yun MM; Xu MB; Wang YZ; Yun S
    Int J Clin Oncol; 2013 Aug; 18(4):657-65. PubMed ID: 22847800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
    Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
    Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor antigen-loaded dendritic cells combined with cytokine-induced killer (CIK) enhance the killing activity of human esophageal cancer cells by promoting ASK1 activation].
    Duan Z; Li H; Hu B; Li Y; Huang L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):501-508. PubMed ID: 37340918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of dendritic cells on biological activity of the homologous CIK cells and its anti-leukemia effect in vitro.
    Wei XC; Zhai XH; Han XR; Yang DD; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):946-51. PubMed ID: 20723306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].
    DU Z; Zhao XL; Gao YT; Wu CX; Wang YJ; Zhu ZY; Sun Q; Fang SC
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):759-63. PubMed ID: 19173806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented CD3(+)CD8(+) and CD3(+)CD56(-) cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor.
    Wang L; Yi Y; Yin D; Zhou Z; Fan J; Ye W; Zhao W
    Cytotherapy; 2016 Apr; 18(4):581-9. PubMed ID: 26971686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells infected by Ad-sh-SOCS1 enhance cytokine-induced killer (CIK) cell immunotherapeutic efficacy in cervical cancer models.
    Zheng Y; Hu B; Xie S; Chen X; Hu Y; Chen W; Li S; Hu B
    Cytotherapy; 2017 May; 19(5):617-628. PubMed ID: 28215653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].
    Yang XJ; Huang JA; Lei W; Zhu YB; Zhang XG
    Ai Zheng; 2006 Nov; 25(11):1329-33. PubMed ID: 17094896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
    Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R
    J Clin Immunol; 2010 Sep; 30(5):766-74. PubMed ID: 20549316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of DC-CIK cells and its effect against leukemia cells in vitro.
    Wei XC; Zhai XH; Han XR; Yang DD; Zhao WL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1150-3. PubMed ID: 18928615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer.
    Que RS; Lin C; Ding GP; Wu ZR; Cao LP
    J Zhejiang Univ Sci B; 2016 May; 17(5):352-60. PubMed ID: 27143262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib indirectly enhanced anti-tumor cytotoxicity of cytokine-induced killer cells and CD3⁺CD56⁺ subset through the co-culturing dendritic cells.
    Wongkajornsilp A; Wamanuttajinda V; Kasetsinsombat K; Duangsa-ard S; Sa-ngiamsuntorn K; Hongeng S; Maneechotesuwan K
    PLoS One; 2013; 8(11):e78980. PubMed ID: 24232460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor effects by the coculture of allotumor RNA-pulsed dendritic cells with autologous cytokine-induced killer cells on hormone-refractory prostate cancer.
    Pang J; Gao X; Liu X; Wang K; Zhang Y; Feng L; Zhan H
    Cancer Invest; 2007; 25(7):527-34. PubMed ID: 17952744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor activity of dendritic cell-cytokine induced killer cells (DC-CIKs) sensitized to HER2 against HER-positive breast cancer cells.
    Wen YY; Hu XS
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.